What are the contraindications for gabapentin (Neurontin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contraindications for Gabapentin

The only absolute contraindication for gabapentin is hypersensitivity to the drug or its ingredients. 1

Primary Contraindications and Precautions

Gabapentin has a remarkably favorable safety profile with minimal absolute contraindications compared to many other medications. However, several important precautions should be considered:

Renal Impairment

  • Gabapentin requires dose adjustment based on creatinine clearance:
    • CrCl ≥60 mL/min: 900-3600 mg/day (300-1200 mg TID)
    • CrCl 30-59 mL/min: 400-1400 mg/day (200-700 mg BID)
    • CrCl 15-29 mL/min: 200-700 mg/day (once daily)
    • CrCl ≤15 mL/min: 100-300 mg/day (once daily) 2

Risk of Falls and Altered Mental Status

  • Increased risk of falls or fractures (RR 1.35) and altered mental status (RR 1.12) compared to non-users
  • Clear dose-response relationship with highest risk at doses ≥2,400 mg/day (RR 1.90 for falls/fractures) 3
  • Particular caution needed in elderly patients who should be started on lower doses and titrated more slowly 2

Pregnancy and Breastfeeding

  • Not recommended for women who are pregnant, actively trying to conceive, or nursing
  • Women of reproductive potential should receive counseling regarding reliable contraception methods 4

Special Population Considerations

Elderly Patients

  • Start with lower doses and titrate more slowly
  • Monitor closely for side effects, particularly dizziness, somnolence, and gait disturbance 2

Patients with History of Substance Abuse

  • Potential for abuse, particularly in patients with:
    • History of opioid abuse
    • Mental illness
    • Previous prescription drug abuse history 5
  • Some states have reclassified gabapentin as a Schedule V controlled substance due to abuse potential 5

Patients on Monoamine Oxidase Inhibitors

  • Unlike some other medications used for neuropathic pain (e.g., phentermine), gabapentin has no known contraindications with MAOIs 4

Common Side Effects to Monitor

  • Dizziness (19% of patients)
  • Somnolence (14%)
  • Peripheral edema (7%)
  • Gait disturbance (14%) 6
  • Side effects typically mild to moderate and usually subside within approximately 10 days from treatment initiation 7

Dosing Considerations

When using gabapentin for unexplained chronic cough or neuropathic pain, start with 300 mg once daily and gradually increase:

  • Day 1: 300 mg once daily
  • Day 2: 600 mg daily (divided)
  • Day 3 onward: 900 mg daily (divided)
  • Additional titration to 1800 mg/day recommended for greater efficacy
  • Some patients may require up to 3600 mg/day 4, 7

Monitoring Recommendations

  • Evaluate response every 2-4 weeks during dose titration
  • Assess improvement in symptoms and monitor for adverse effects
  • Consider discontinuation if inadequate response after 4-8 weeks at maximum tolerated dose 2

Gabapentin's favorable safety profile with minimal drug interactions makes it a versatile option for various conditions, but careful consideration of patient-specific factors and appropriate dose adjustments are essential for safe and effective use.

References

Guideline

Neuropathic Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Gabapentin controlled substance status.

Journal of the American Pharmacists Association : JAPhA, 2021

Research

Gabapentin for chronic neuropathic pain in adults.

The Cochrane database of systematic reviews, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.